SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-002174
Filing Date
2019-01-22
Accepted
2019-01-22 07:00:23
Documents
5
Period of Report
2019-01-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv511309_8k.htm 8-K 18448
2 EXHIBIT 99.1 tv511309_ex99-1.htm EX-99.1 21071
3 GRAPHIC image_004.jpg GRAPHIC 5964
4 GRAPHIC image_002.jpg GRAPHIC 71936
5 GRAPHIC image_003.jpg GRAPHIC 28964
  Complete submission text file 0001144204-19-002174.txt   188257
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 19534251
SIC: 8731 Services-Commercial Physical & Biological Research